RxDoctor Payments DataLook up a doctor →

Benjamin Levinson, MD

Internal Medicine · Irmo, SCNPI 1346208865

Payments from drug & device makers

$12,222in general payments, 2019–2025

Across 807 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Novo Nordisk$839
  • Lilly USA, LLC$647
  • Otsuka America Pharmaceutical, Inc.$546
  • Amarin Pharma, Inc.$528
  • plus $6K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)166$1,744
AstraZeneca(2 entities)74$1,471
Novo Nordisk44$839
Lilly USA, LLC53$647
Otsuka America Pharmaceutical, Inc.30$546
Amarin Pharma, Inc.38$528
Bayer28$498
Johnson & Johnson34$487
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC31$454
Amgen31$426
Boehringer Ingelheim32$418
Abbott27$414
Novartis24$394
Astellas Pharma US Inc16$364
Sanofi-aventis U.S. LLC20$356
Corcept Therapeutics12$262
Merck14$177
Axsome Therapeutics, Inc.7$149
Takeda Pharmaceuticals U.S.A., Inc.9$140
Medtronic8$119
Arbor Pharmaceuticals, Inc.9$118
Boston Scientific5$118
Jazz Pharmaceuticals Inc.7$117
Exact Sciences8$112
Biohaven Pharmaceutical Holding Company Ltd.6$103
Noven Therapeutics, LLC4$92
Pfizer6$85
Esperion Therapeutics, Inc.5$79
Biohaven Pharmaceuticals, Inc.4$67
Upsher-smith Laboratories LLC5$66
Endo Pharmaceuticals Inc.4$62
Inari Medical, Inc.2$62
GSK4$55
Teva Pharmaceuticals USA, Inc.4$55
Aimmune Therapeutics, Inc.3$51
Phathom Pharmaceuticals, Inc.3$48
Edwards Lifesciences2$45
Eisai Inc.3$44
Supernus Pharmaceuticals, Inc.2$39
Lundbeck LLC2$36
Mannkind Corporation2$36
Antares Pharma, Inc.2$28
Recordati_rare_diseases_inc.1$27
Stryker1$22
Hikma Pharmaceuticals USA1$21
Aytu Biopharma, Inc.1$20
Dexcom, Inc.1$19
Intra-sana Laboratories1$16
Adlon Therapeutics L.p.1$16
Aclaris Therapeutics, Inc.1$16
Teleflex LLC1$15
Ironwood Pharmaceuticals, Inc1$15
Bausch Health US, LLC1$15
Cvrx, Inc.1$13
Insmed, Inc.1$13
Nestle Healthcare Nutrition Inc.1$12
Intersect ENT, Inc.1$12
Genentech USA, Inc.1$12
Prugen, Inc. Pharmaceuticals1$5

How this compares

$12,222 in reported general payments places this provider in the 95th percentile of 1,498 internal medicine providers in South Carolina.

See all internal medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$423,980
Medicare patients
714
Services billed
6,670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Irmo

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →